Case ReportInternational Journal of Basic & Clinical Pharmacology
Publication: Olanzapine induced hyperprolactinemia
Int J Basic Clin Pharmacol. 2013;2(6):836-837.DOI10.5455/2319-2003.ijbcp20131234
Abstract
Olanzapine, a second generation antipsychotic is widely used for the treatment of schizophrenia and bipolar disorders. Though olanzapine is an efficacious antipsychotic it has been associated with many adverse effects like weight gain, hyperlipidemia, diabetes mellitus, etc necessitating its discontinuation. Here, we present two cases of hyperprolactinemia induced by olanzapine.
Keywords
Affiliations
- Department of Pharmacology, Kasturba Medical College, Manipal University, Manipal, Karnataka, India
- Psychiatrist, Dr. A.V. Baliga Memorial Hospital, Udupi, Karnataka, India
